SGAM
Smith Group Asset Management Portfolio holdings
AUM
$1.53B
1-Year Return
38.67%
This Quarter Return
+7.77%
1 Year Return
+38.67%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$3.38B
AUM Growth
+$750M
(+28%)
Cap. Flow
+$668M
Cap. Flow
% of AUM
19.75%
Top 10 Holdings %
Top 10 Hldgs %
27.81%
Holding
544
New
135
Increased
136
Reduced
129
Closed
73
Top Buys
| 1 |
Microsoft
MSFT
|
$100M |
| 2 |
Apple
AAPL
|
$47.4M |
| 3 |
Masco
MAS
|
$45.4M |
| 4 |
McDonald's
MCD
|
$44.7M |
| 5 |
Campbell Soup
CPB
|
$37.4M |
Top Sells
| 1 |
F5
FFIV
|
$49M |
| 2 |
MSCI
MSCI
|
$30.2M |
| 3 |
Pilgrim's Pride
PPC
|
$29.4M |
| 4 |
Amdocs
DOX
|
$22.9M |
| 5 |
ANSS
Ansys
ANSS
|
$21.3M |
Sector Composition
| 1 | Consumer Discretionary | 19.08% |
| 2 | Healthcare | 18.13% |
| 3 | Technology | 17.51% |
| 4 | Industrials | 12.07% |
| 5 | Consumer Staples | 10.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHMT
176
DELISTED
Chemtura Corporation
CHMT
| $895K | 0.03% |
+32,830
| New | +$895K |
|
177
Inovio Pharmaceuticals
INO
$146M
| $870K | 0.03% |
10,785
-1,709
| -14% | -$138K |
|
178
Ultragenyx Pharmaceutical
RARE
$3.01B
| $856K | 0.03% |
+7,630
| New | +$856K |
|
|
ANAC
179
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $851K | 0.03% |
7,530
+3,420
| +83% | +$387K |
|
|
ARMH
180
DELISTED
ARM HOLDINGS PLC ADS
ARMH
| $845K | 0.03% |
+18,683
| New | +$845K |
|
181
Ziff Davis
ZD
$1.53B
| $826K | 0.02% |
+11,546
| New | +$826K |
|
|
SCAI
182
DELISTED
Surgical Care Affiliates, Inc.
SCAI
| $803K | 0.02% |
20,180
-3,500
| -15% | -$139K |
|
183
BioCryst Pharmaceuticals
BCRX
$1.74B
| $789K | 0.02% |
+76,410
| New | +$789K |
|
184
Halozyme
HALO
$8.59B
| $752K | 0.02% |
43,380
-6,700
| -13% | -$116K |
|
185
Cohen & Steers
CNS
$3.71B
| $725K | 0.02% |
+23,800
| New | +$725K |
|
|
BERY
186
DELISTED
Berry Global Group, Inc.
BERY
| $690K | 0.02% |
+20,778
| New | +$690K |
|
|
CERN
187
DELISTED
Cerner Corp
CERN
| $688K | 0.02% |
+11,429
| New | +$688K |
|
|
NAVG
188
DELISTED
Navigators Group Inc
NAVG
| $686K | 0.02% |
15,986
-2,400
| -13% | -$103K |
|
189
V2X
VVX
$1.75B
| $678K | 0.02% |
+32,440
| New | +$678K |
|
190
Myriad Genetics
MYGN
$632M
| $650K | 0.02% |
+15,060
| New | +$650K |
|
191
WSFS Financial
WSFS
$3.27B
| $628K | 0.02% |
19,400
+15,560
| +405% | +$504K |
|
192
Heidrick & Struggles
HSII
$1.05B
| $618K | 0.02% |
+22,690
| New | +$618K |
|
|
DTSI
193
DELISTED
DTS, Inc.
DTSI
| $615K | 0.02% |
27,250
-2,340
| -8% | -$52.8K |
|
194
Merck
MRK
$210B
| $613K | 0.02% |
12,164
+12,136
| +43,343% | +$612K |
|
|
CPHD
195
DELISTED
Cepheid Inc
CPHD
| $609K | 0.02% |
+16,670
| New | +$609K |
|
196
Acadia Pharmaceuticals
ACAD
$4.3B
| $601K | 0.02% |
+16,870
| New | +$601K |
|
|
ALJ
197
DELISTED
Alon U S A Energy Inc
ALJ
| $572K | 0.02% |
38,560
-5,900
| -13% | -$87.5K |
|
198
Regional Management Corp
RM
$429M
| $545K | 0.02% |
35,210
+30,520
| +651% | +$472K |
|
199
American Express
AXP
$230B
| $525K | 0.02% |
+7,551
| New | +$525K |
|
|
PTLA
200
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $511K | 0.02% |
+9,940
| New | +$511K |
|